M&A Deal Summary |
|
|---|---|
| Date | 2020-02-12 |
| Target | Wockhardt - Select Business Divisions |
| Sector | Life Science |
| Buyer(s) | Dr. Reddy s Laboratories |
| Sellers(s) | Wockhardt |
| Deal Type | Divestiture |
| Deal Value | 18.5B INR |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1984 |
| Sector | Medical Products |
| Employees | 27,811 |
| Revenue | 325.5B INR (2025) |
Dr. Reddy’s Laboratories is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets. Dr. Reddy's Laboratories was founded in 1984 and is based in Hyderabad, Telangana.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 6 |
| Sector: Life Science M&A | 3 of 5 |
| Type: Divestiture M&A Deals | 1 of 3 |
| Country: India M&A | 2 of 3 |
| Year: 2020 M&A | 1 of 2 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-02 |
SERNIVO Spray
Malvern, Pennsylvania, United States SERNIVO Spray is used to treat a type of skin condition (plaque psoriasis). Betamethasone reduces the swelling, itching, and redness that may occur with plaque psoriasis. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-11-28 |
Glenmark Pharmaceuticals - Anti-Allergy Brands
India Glenmark Pharmaceuticals Ltd. - Anti-Allergy Brands comprises Momat Rino, Momat Rino Advance, Momat A, Glenspray, and Glenspray Active that represent two types of products, (a) mometasone mono-product and (b) combination of mometasone with azelastine, and are indicated for the treatment of Seasonal and Perennial Allergic Rhinitis. |
Buy | - |
Wockhardt is a high technology global pharmaceuticals and biotechnology major with innovative multi-disciplinary research and development programmes. It has 5 research centres and 21 world-class manufacturing plants in India, USA, UK, France and Ireland.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: India M&A | 2 of 2 |
| Year: 2020 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-08-02 |
Wockhardt - Nutrition Business & Brands
Mumbai,, India Wockhardt - Nutrition Business & Brands comprises pediatric, adult nutritional brands, and manufacturing facilities. |
Sell | €250M |
